Lacosamide Tablet, Film Coated
Product Images NDC 65862-749

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 65862-749). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose)

The text is a description of figure 1 showing the median percent reduction in seizure frequency per 28 days from baseline to the maintenance phase by dose. It includes results from four different studies of a medication called Lacosamide compared to placebo. Each study is divided into different Lacosamide dosages (200, 400, or 600 my/day) with varied percentages of reduction in seizure frequency as compared to placebo. The text also notes statistically significant differences between Lacosamide and placebo.*

FDA Label Image

Package Label-principal Display Panel (200 mg (3 x 10) Unit-dose Tablets)

This is a description of Lacosamide Tablets, USP consisting of 30 unit-dose tablets, with each film-coated tablet containing 200mg of Lacosamide USP. Dosage information can be found in the package insert. The tablets should be stored at a temperature between 20° to 25°C. This unit-dose package is child-resistant. The medication guide provided should be separately dispensed for each patient by the pharmacist. The manufacturer of the tablets is Aurobindo, and the package code is TS/DRUGS 222008.*

FDA Label Image

Figure 2 (Proportion of Patients by Response Rate for Lacosamide and Placebo Groups in Studies 2, 3, and 4)

The text describes Figure 2 showing the proportion of patients by responder rate for Lacosamide and Placebo groups in Studies 2, 3, and 4. The figure contains a table with four columns showing the percentage of patients under four treatment groups: Placebo (N=359), Lacosamide 200 mg/day (N=267), Lacosamide 400 mg/day (N=466), and Lacosamide 600 mg/day (N=202). The rows indicate the proportion of patients in each group with different responder rates ranging from 0% to 100%. No further information is available.*

FDA Label Image

Package Label-principal Display Panel (50 mg (60 Tablets Bottle))

FDA Label Image

Package Label-principal Display Panel (50 mg (3 x 10) Unit-dose Tablets)

This text describes a medication called Lacosamide Tablets, USP. It comes in a package of 30 (3 x 10) unit-dose tablets, each containing 50mg of Lacosamide. The package insert should be consulted for dosage information. The tablets should be stored at room temperature between 20-25°C. The medication guide provided separately should be dispensed to each patient. The package is child-resistant. The medication is manufactured by Aurobindo, and the company's address is given.*

FDA Label Image

Package Label-principal Display Panel (100 mg (60 Tablets Bottle))

Lacosamide Tablets, USP are available in a bottle of 60 tablets with each tablet containing 100 mg of Lacosamide USP. They are meant to be taken only on prescription, and the physician should provide the patient with a medication guide. The usual dosage information is provided in the package insert. The tablets should be stored between 20° to 25°C. The manufacturer is Aurobindo Pharma USA Inc., and the tablets have been made in India. The product code is P1428070.*

FDA Label Image

Package Label-principal Display Panel (100 mg (3 x 10) Unit-dose Tablets)

Lacosamide Tablets, USP are film-coated tablets available in 100 mg strength with 30 unit-dose tablets in each container. It contains Lacosamide USP 100 as active ingredient typically used as per dosage information. The tablets should be stored in a container that resistant to heat and should be kept at room temperature, around 20°C to 25°C. This medicine is to be dispensed only to outpatients and a medication guide should be provided to each patient along. The manufacturer is Aurobindo with the address 279 Princeton St Road, Rosbecs brahma ush, C. The National Drug Code (NDC) of Lacosamide Tablets, USP is 65862-748-03.*

FDA Label Image

Package Label-principal Display Panel (150 mg (60 Tablets Bottle))

This is a prescription drug called Lacosamide Tablets, USP which comes in 60 film-coated tablets with each tablet containing 150mg of Lacosamide USP. The drug is distributed by Aurobindo Pharma USA, Inc. with an address in East Windsor, NJ. The usual dosage of the drug can be found in the package insert. The drug must be stored at a temperature ranging from 20°C to 25°C. Pharmacists are advised to dispense the Medication Guide to each patient separately.*

FDA Label Image

Package Label-principal Display Panel (150 mg (3 x 10) Unit-dose Tablets)

This is a description for Lacosamide Tablets, USP. The package contains 30 unit-dose tablets which are child-resistant. Each film-coated tablet contains 150 Lacosamide USP. There is a package insert for dosage information. The tablets should be stored at 20° to 25°C (68° to 77°F). The tablets are distributed by Aurobindo Pharma USA, Inc. with a code of TSDRUGS22/2009. The product is made in India.*

FDA Label Image

Package Label-principal Display Panel (200 mg (60 Tablets Bottle))

This is a description of a prescription drug called Lacosamide Tablets, USP by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 200mg of Lacosamide USP. It is advised to dispense the medication guide provided separately to each patient. As per the usual dosage, see package insert for dosage information. Store the tablets at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. The code on the package is TS/DRUGS/22/2009.*

FDA Label Image

Str (Lacosamide Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.